DR. SCHAUFLER ACCESS ADVISORY
Dr. Thilo Schaufler portrait

About Dr. Thilo Schaufler

Building clarity at the intersection of strategy, evidence, and leadership.

I founded Dr. Schaufler Access Advisory to help Market Access leaders and their organizations navigate complex environments with confidence. During my years leading global teams, I often wished for a true sparring partner — someone who could bring an outside perspective, challenge constructively, and help turn good ideas into great strategies.

As a Strategic Catalyst, I work alongside clients to sharpen strategic thinking, strengthen evidence narratives, and build the executive presence required to make impact visible — both internally and externally.

After nearly two decades in the biopharmaceutical industry, I’ve learned that great strategies don’t just depend on smart thinking — they also need to be heard. That requires both evidence and leadership presence. My work bridges those dimensions, helping strategies stand up — to payers, policymakers, and management alike.

How I Work

Every engagement starts with clarity — aligning insights, narratives, and leadership impact. I combine analytical depth with strategic empathy, helping clients see complexity clearly and act decisively. No layers, no templates — just peer-to-peer collaboration focused on co-creating outcomes that stand up.

Experience

Independent Consultant (since 2025)
Founder of Dr. Schaufler Access Advisory.
Support biopharma leaders on access, evidence, and policy strategy while strengthening executive presence.
Advise venture capital firms and institutional investors to pressure-test clinical and commercial assumptions for realistic asset valuations.
Share 20 years of industry experience with non-profit organizations to contribute to global health initiatives.

CSL Vifor (7 years)
Up to Global Head Health Economics and Outcomes Research.
Led global HEOR and launch strategies across nephrology and rare disease portfolios, including early access and evidence generation initiatives.

F. Hoffmann-La Roche (3 years)
Senior International Health Policy Leader, Global Access.
Developed cross-regional policy initiatives, Market Access strategies, and capability-building programs across emerging and established markets.

AbbVie (4 years)
Up to Global Market Access Lead.
Directed payer value strategy development and local reimbursement submissions; established special access pathways for innovative therapies.

Amgen (3 years)
Health Economics Manager.
Worked with clinical and academic partners to integrate real-world evidence into access planning and led local reimbursement submissions.

Pfizer (2 years)
Junior Manager Public Affairs.
Designed and executed policy initiatives and stakeholder events linking public health priorities with pharmaceutical innovation.

Education & Executive Development

  • Dr. rer. pol. in Economics, University of Mannheim, Germany
  • Magister Artium (M.A.) in Political Science and Economics, University of Mannheim, Germany
  • Executive Education in Leadership, Strategy & Corporate Finance, Saïd Business School, University of Oxford
  • Courses on Leadership, Negotiation and Artificial Intelligence, HarvardX, Vanderbilt University, American Negotiation Institute
← Back to Home